Investigational drug · Phase 3
DFL24498
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Dry Eye Disease (DED), Atopic Keratoconjunctivitis.
Phase 3Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
2
Any phase or sponsor naming "DFL24498"
First trial start
2025
Dec 1, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "DFL24498", any sponsor or status.
Conditions studied
As listed on its trial records.
- Dry Eye Disease (DED)
- Atopic Keratoconjunctivitis
Approved drugs for the same conditions: Dry eye disease · Ophthalmology
Largest trials
Live from ClinicalTrials.gov: studies naming "DFL24498" as an intervention, largest first.
- An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye DiseasePivotal-lookingRecruiting
Dompé Farmaceutici S.p.AIndustry
NCT07503886 · 417 participants (planned) · Start May 12, 2026 · Primary completion Dec 27, 2026
Drug: DFL24498 · For: Dry Eye Disease (DED)
Sites: Chandler, Arizona; Azusa, California; Glendale, California · 24 sites in all
- An Efficacy and Safety Study of DFL24498 in the Treatment of AKCPivotal-lookingRecruiting
Dompé Farmaceutici S.p.AIndustry
NCT07395232 · 153 participants (planned) · Start Dec 1, 2025 · Primary completion Mar 2027
Drug: DFL24498; Vehicle and 1 more · For: Atopic Keratoconjunctivitis
Sites: Jacksonville, Florida; Miami, Florida; Morrow, Georgia · 19 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Dry Eye Disease (DED)
- licaminlimabPhase 31 trial
Oculis · Dry Eye Disease (DED)
- 0.25% RCI001RCI001Phase 22 trials
ORA, Inc. · Dry Eye Disease (DED), Dry Eye
- TTAX03Phase 22 trials
BioTissue Holdings, Inc · Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis
- BRM421Phase 21 trial
BRIM Biotechnology Inc. · Dry Eye Disease (DED), Keratoconjunctivitis Sicca
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.